Franklin Prescriptions, Inc., T/a Franklin Drug Center v. New York Times Co., Sandra Coburn, John Doe, Jane Doe, Franklin Prescriptions, Inc.

424 F.3d 336, 33 Media L. Rep. (BNA) 2254, 2005 U.S. App. LEXIS 19586, 2005 WL 2179849
CourtCourt of Appeals for the Third Circuit
DecidedSeptember 12, 2005
Docket04-3404
StatusPublished
Cited by81 cases

This text of 424 F.3d 336 (Franklin Prescriptions, Inc., T/a Franklin Drug Center v. New York Times Co., Sandra Coburn, John Doe, Jane Doe, Franklin Prescriptions, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Franklin Prescriptions, Inc., T/a Franklin Drug Center v. New York Times Co., Sandra Coburn, John Doe, Jane Doe, Franklin Prescriptions, Inc., 424 F.3d 336, 33 Media L. Rep. (BNA) 2254, 2005 U.S. App. LEXIS 19586, 2005 WL 2179849 (3d Cir. 2005).

Opinion

OPINION OF THE COURT

SCIRICA, Chief Judge.

Plaintiff/Appellant Franklin Prescriptions challenges the jury instructions in this defamation action under Pennsylvania law. At issue is whether plaintiff properly objected to the court’s jury charge under Federal Rule of Civil Procedure 51, and whether plaintiff was entitled to an instruction on presumed damages and defamation per se. The District Court denied Franklin Prescriptions’ motion for a new trial. We will affirm.

I.

Franklin Prescriptions, Inc., is a small pharmacy in Philadelphia specializing in fertility medications. In 1996, the company began marketing its niche products on the internet via an information-only website. The website allows Franklin Prescriptions’ customers to survey available products and pricing, but does not enable the online purchase of prescription drugs. Franklin Prescriptions only accepts drug orders by way of mail, telephone, fax, or in person, and only then with a doctor’s prescription.

On October 25, 2000, the New York Times published an article entitled, “A *338 Web Bazaar Turns into a Pharmaceutical Free For All.” The article addressed the risks of purchasing fertility drugs on the internet. It described “unscrupulous” and “cloak and dagger” websites that process online orders for controlled drugs without prescriptions. Franklin Prescriptions was not mentioned in the text, but the article contained a graphic insert with an image of the Franklin Prescriptions website that identified Franklin Prescriptions by name. The insert was placed next to a side-bar labeled “Safety Tips for Buying E-Medicines” that warned readers to “[a]void sites that fail or refuse to provide a United States address and phone number.” Although Franklin Prescriptions’ website did, in fact, list the company’s address and telephone number, the partial image reproduced for the article omitted this information. Significantly, the published image also omitted part of the website that stated in bold-face language: “Must have doctor’s prescription from a physician licensed in the United States to purchase Viagra.”

Franklin Prescriptions sued for defamation. The District Court denied the New York Times’ motion for summary judgment, finding a genuine issue of material fact on whether the newspaper published the article with reckless disregard for its falsity. The case went to trial, and the jury found the article false and defamatory. But it awarded no damages, finding Franklin Prescriptions suffered no actual harm caused by the publication.

Before the jury was charged, Franklin Prescriptions submitted proposed jury instructions on presumed damages and defamation per se. Neither proposed instruction was given to the jury. The parties dispute whether Franklin Prescriptions objected to the lack of a presumed damages instruction. Franklin Prescriptions submits that it did so — off the record — at an in camera charging conference held in chambers. The New York Times disputes this contention, maintaining that the presumed damages instruction was not discussed at the chambers charging conference. In its Memorandum Opinion and Order, the District Court rejected Franklin Prescriptions’ assertion, stating that “the Court terminated the conference before addressing Plaintiffs presumed damages instruction.” Franklin Prescriptions, Inc. v. The New York Times Co., 2004 WL 1770296, at *5 (E.D.Pa. Aug. 5, 2004). Whether or not an objection was raised at the charging conference, it is undisputed that Franklin Prescriptions never entered an on-the-record objection to the lack of a presumed damages instruction.

In denying the motion for a new trial, the District Court held that Franklin Prescriptions failed to object to the lack of a presumed damages instruction under Fed. R.Civ.P. 51(c)(1), which provides that a party objecting to jury instructions “must do so on the record.” Additionally, the District Court held that under Pennsylvania law Franklin Prescriptions was not entitled to a jury instruction on presumed damages. Franklin Prescriptions, 2004 WL 1770296, at *7-8.

II.

The District Court had diversity jurisdiction under 28 U.S.C. § 1332. We have appellate jurisdiction under 28 U.S.C. § 1291. Our standard of review turns on whether Franklin Prescriptions properly objected to the relevant jury charge. Where a party properly objects to a jury instruction under Fed.R.Civ.P. 51, we exercise plenary review to determine whether the instruction misstated the applicable law. Cooper Distrib. Co., Inc. v. Amana Refrigeration, Inc., 180 F.3d 542, 549 (3d Cir.1999) (citing Walden v. Georgia-Pac. Corp., 126 F.3d 506, 513 (3d Cir.1997)). *339 Where a party fails to object properly, we may review for “plain error in the instructions affecting substantial rights.” Fed. R.Civ.P. 51(d)(2). Under the discretionary plain error standard, we will reverse the trial court only where a plain error was “fundamental and highly prejudicial, such that the instructions failed to provide the jury with adequate guidance and our refusal to consider the issue would result in a miscarriage of justice.” Ryder v. Westinghouse Elec. Corp., 128 F.3d 128, 136 (3d Cir.1997).

III.

A.

The District Court held that Franklin Prescriptions failed to preserve its presumed damages objection under Federal Rule of Civil Procedure 51(c)(1), which provides that a party objecting “to an instruction or the failure to give an instruction must do so on the record, stating distinctly the matter objected to and the grounds of the objection.” Notwithstanding the plain language of Rule 51, Franklin Prescriptions contends it preserved its objection by submitting a formal request for a presumed damages charge and by pressing for that instruction during the in camera charging conference.

Merely proposing a jury instruction that differs from the charge given is insufficient to preserve an objection. Abuan v. Level 3 Communications, Inc., 353 F.3d 1158, 1172 (10th Cir.2003); Caruso v. Forslund, 47 F.3d 27, 31 (2d Cir.1995); Advisory Committee Note to Fed.R.Civ.P.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

BROWN v. WILSON
W.D. Pennsylvania, 2025
ALVARADO v. CITY OF PHILADELPHIA
E.D. Pennsylvania, 2025
Gartor Brown v. Maxwell
Third Circuit, 2024
Paulette Barclift v. Keystone Credit Services LLC
93 F.4th 136 (Third Circuit, 2024)
DOE v. HAVERFORD COLLEGE
E.D. Pennsylvania, 2023
United States v. Stamatios Kousisis
66 F.4th 406 (Third Circuit, 2023)
Marnie O'Brien v. The Middle East Forum
57 F.4th 110 (Third Circuit, 2023)
Dewayne Bearchild v. Kristy Cobban
947 F.3d 1130 (Ninth Circuit, 2020)
Tamra Robinson v. First State Community Action A
920 F.3d 182 (Third Circuit, 2019)
Lance Yarus v. Walgreen Co
Third Circuit, 2018
Marie DiFiore v. CSL Behring LLC
879 F.3d 71 (Third Circuit, 2018)
Liudmila Muraveva v. Shawn Toffoli
709 F. App'x 131 (Third Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
424 F.3d 336, 33 Media L. Rep. (BNA) 2254, 2005 U.S. App. LEXIS 19586, 2005 WL 2179849, Counsel Stack Legal Research, https://law.counselstack.com/opinion/franklin-prescriptions-inc-ta-franklin-drug-center-v-new-york-times-ca3-2005.